相关实验视频
Updated: Jul 12, 2026

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.4K
潜在的膀癌治疗输送系统:最近的更新
Oluwadamilola M Kolawole1, Vitaliy V Khutoryanskiy2
1Department of Pharmaceutics and Pharmaceutical Technology, University of Lagos, Lagos, Nigeria.
Expert opinion on drug delivery
|August 23, 2024
概括
开发先进的药物递送系统,如凝系统中的功能化纳米粒子,提供了改善的膀癌治疗,控制释放和瘤向. 未来的研究可能涉及组合疗法和智能纳米材料,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 膀癌的治疗是昂贵的,因为需要治疗和监测.
- 对于有效的,有针对性的药物配方,以改善患者预后,有着至关重要的需求.
- 目前的治疗方法在药物释放控制和瘤特异性方面面临挑战.
研究的目的:
- 在过去十年中,审查膀癌治疗药物配方.
- 为了突出最近的进展,临床试验和FDA批准的药物.
- 识别阻碍有希望的药物输送系统临床转化障碍的障碍.
主要方法:
- 关于膀癌药物配方的科学文献的综述.
- 对膀癌治疗策略的最新趋势的分析.
- 检查临床试验数据和监管部门的批准.
主要成果:
- 在in situ凝系统中的表面功能化纳米颗粒增强了受控的药物释放.
- 这些先进的系统显示出改善膀癌治疗预后的潜力.
- 在将实验室研究转化为临床应用方面仍然存在挑战.
结论:
- 带有表面功能化和现场凝的颗粒物药物递送系统对膀癌有很大的前景.
- 未来的方向包括多药物系统和像光热疗法这样的智能纳米材料.
- 克服转化障碍是改善膀癌患者治疗结果的关键.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

